Filing Flows › LifeStance Health Group (LFST) › Q4 2025
LifeStance Health Group (LFST) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 25, 2026
LifeStance Health Group (LFST) reported revenue of $382M for the fourth quarter 2025 (Q4 2025), +17% from a year earlier and +5% from the quarter before. Operating margin was 4.7%, net earnings $11.7M (3.1% of revenue).
LifeStance Health Group, Q4 2025: revenue $382M (+17% year over year), operating margin 4.7%, net earnings $11.7M, operating cash flow $57.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $382M | +5% | +17% |
| Operating profit | $18.1M | +144% | 17× |
| Net earnings | $11.7M | +983% | — |
| Operating cash flow | $57.6M | +111% | -8% |
| Free cash flow | $46.6M | +174% | -17% |
What changed
Revenue was $382.2M in Q4 2025, up 17% year over year and up 5% from the previous quarter.
Operating profit was $18.1M, a 4.7% margin (up 4.4 points year over year). Of the extra revenue versus a year earlier, 30% reached operating profit, above the 0% margin then. Total costs grew 12% against revenue growth of 17%. The fastest-growing cost line was Other operating costs (+17%). Net earnings were $11.7M. The effective tax rate was 23.3%.
Operating cash flow was $57.6M (down 8% year over year), 493% of net earnings. Non-cash charges added back $10.3M of depreciation and amortization and $16.7M of share-based compensation. Working capital and other items added $18.8M. Capital expenditures of $10.9M left free cash flow of $46.6M.
Questions
What was LifeStance Health Group's revenue in the fourth quarter 2025?
LifeStance Health Group (LFST) reported revenue of $382M for the fourth quarter 2025 (Q4 2025), +17% from a year earlier and +5% from the quarter before.
Was LifeStance Health Group profitable in the fourth quarter 2025?
Operating profit was $18.1M (4.7% of revenue) and net earnings $11.7M.